{"id":798621,"date":"2025-01-07T12:42:51","date_gmt":"2025-01-07T17:42:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/"},"modified":"2025-01-07T12:42:51","modified_gmt":"2025-01-07T17:42:51","slug":"lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/","title":{"rendered":"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Jan.  07, 2025  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of <strong>Kyverna Therapeutics, Inc. (NASDAQ: KYTX).<\/strong><\/p>\n<p>Shareholders who purchased shares of KYTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y4ZM56oFuZ_kFhuomyXJvaY8Q0zwO1F5bVy-qrTjfXme5Xi65o3DELK-egJ2NBehaBPDS_FE2_5C9aA1oYc55lc5pzvEENFvPxCEui4QbzFFaQv5VnoxDeZpt0AxBWK8qaq0Rn-s7d0lvI4YAKHmT2z5N5VCJErGwUrG1QxGX5xr4WvN8pgrpWcicuANTqNqvfmFT-1UmG9qaJAatMvgzcaH7VgT0dMgejNq1FI4PznGhOCKUcKxT4Qc_I4qRZkMRr3DskRAhO8p0ya_U32XVzQI9KXteWnLoetJtt-cLyX7UgPjK7AD4txc3GD2BKJy\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/kyverna-therapeutics-inc-loss-submission-form\/?id=120906&amp;from=3<\/a>\u00a0<\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company&#8217;s offering documents issued in connection with its February 2024 initial public offering.<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) the strategy to best accomplish the IPO; (ii) the terms of the IPO, including the price at which Kyverna\u2019s common stock would be sold; (iii) the language to be used in the Offering Documents; (iv) what disclosures about Kyverna would be made in the Offering Documents; and (v) what responses would be made to the SEC in connection with its review of the Offering Documents. As a result of those constant contacts and communications between the underwriter defendants\u2019 representatives and Kyverna\u2019s management, directors, and lawyers, at a minimum, the underwriter defendants should have known of Kyverna\u2019s undisclosed then-existing problems and plans, and the Offering Document\u2019s materially inaccurate, misleading, and incomplete statements and omissions, as detailed herein.<\/p>\n<p>\n        <strong>DEADLINE: February 7, 2025<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y4ZM56oFuZ_kFhuomyXJvaY8Q0zwO1F5bVy-qrTjfXme5Xi65o3DELK-egJ2NBehaBPDS_FE2_5C9aA1oYc55lc5pzvEENFvPxCEui4QbzFFaQv5VnoxDeZpt0AxBWK8qaq0Rn-s7d0lvI4YAKHmTw8-we-vCk49VJ9twauN0ffSFNReRO5CZXc6wB4tH5N5Xki17rqNpqxQT6qmjiA3OXQqRyJc4p7iuGKvt4vJ-Q9mT8IUGJhLfy_ZFz22taZClJdWXKtGCT51yU4iRD1MEvfBCeI0DVbMYsZYelzap3-z_weL0a8xFfkbiYr9eKwp\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/kyverna-therapeutics-inc-loss-submission-form\/?id=120906&amp;from=3<\/a>\u00a0<\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of KYTX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 7, 2025. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ntbxPKnD0VcPJFcqvTByF8aTXQANiWTBxu2H0iMpYVu2rbyj5Dj3MgqoPnygBldY07WZ5UHtmi50iwcvlWGQHbbikSdNcbyJwmECn62C_Li7RPtiWvorRp0XcyxfRxSF\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a>\u00a0<br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmZjY2ZjNzQtNjZjOC00MzVjLWEyNDgtZDhkN2JjNjgwZGI2LTEyNzA0Njc=\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX). Shareholders who purchased shares of KYTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/kyverna-therapeutics-inc-loss-submission-form\/?id=120906&amp;from=3\u00a0 CLASS PERIOD: This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company&#8217;s offering documents issued in connection with its February 2024 initial public offering. ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-798621","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX). Shareholders who purchased shares of KYTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/kyverna-therapeutics-inc-loss-submission-form\/?id=120906&amp;from=3\u00a0 CLASS PERIOD: This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company&#8217;s offering documents issued in connection with its February 2024 initial public offering. ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) &hellip; Continue reading &quot;Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-07T17:42:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm\",\"datePublished\":\"2025-01-07T17:42:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/\"},\"wordCount\":478,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/\",\"name\":\"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=\",\"datePublished\":\"2025-01-07T17:42:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm - Market Newsdesk","og_description":"NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX). Shareholders who purchased shares of KYTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/kyverna-therapeutics-inc-loss-submission-form\/?id=120906&amp;from=3\u00a0 CLASS PERIOD: This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company&#8217;s offering documents issued in connection with its February 2024 initial public offering. ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) &hellip; Continue reading \"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-07T17:42:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm","datePublished":"2025-01-07T17:42:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/"},"wordCount":478,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/","name":"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=","datePublished":"2025-01-07T17:42:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzU1NSM2NjgxMzI0IzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-on-kyverna-therapeutics-inc-kytx-join-class-action-suit-seeking-recovery-contact-the-gross-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery \u2013 Contact The Gross Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=798621"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798621\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=798621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=798621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=798621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}